trending Market Intelligence /marketintelligence/en/news-insights/trending/ct92yvvgjpthin8gcjaihw2 content esgSubNav
In This List

Zosano Pharma boosts management team with new CFO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Zosano Pharma boosts management team with new CFO

Zosano Pharma Corp., a clinical-stage biopharmaceutical company, has appointed Greg Kitchener as CFO.

Kitchener was previously CFO and executive vice president at specialty pharmaceutical company BioPharmX Corp.

Fremont, Calif.-based Zosano Pharma is a clinical-stage biopharmaceutical company that provides therapeutics to patients with migraines using its Adhesive Dermally-Applied Microneedle System.